Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma

Journal of Clinical Oncology

Volumn 15, Issue 7, 1997, Pages 2570-2578

  Imazono, Yoshiharu ^a   Takebayashi, Yuji ^a   Nishiyama, Kenryu ^a   Akiba, Suminori ^a   Miyadera, Kazutaka ^a   Yamada, Yuji ^a   Akiyama, Shin Ichi ^a   Ohi, Yoshitada ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR BLOOD FLOW;

EID: 0030758780     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1997.15.7.2570     Document Type: Article

References (50)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6, 1990
2. Folkman J, Watson K, Ingber D, et al: Induction of angiogenesis during the transition from hyperplasia to neoplasm. Nature 339:58-61, 1989
3. Takahashi A, Sasaki H, Kim SJ, et al: Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233-4237, 1994
4. Yoshino S, Kato M, Okada K: Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol 2:156-160, 1995
5. Maclennan GT, Bostwick DG: Microvessel density in renal cell carcinoma: Lack of prognostic significance. Urology 46:27-30, 1995
6. Friedkin M, Roberts D: The enzymatic synthesis of nucleoside synthesis, an efficient method employing nucleoside phosphorylase. J Biol Chem 207:245-256, 1954
7. Krenistky TA, Koszalka GW, Tuttle JV: Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylases. Biochemistry 20:3615-3621, 1981
8. Iltzsch MH, Kouni MH, Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24:6799-6807, 1985
9. Zimmerman M, Seidenberg J: Deoxyribosyl transfer. J Biol Chem 230:2618-2621, 1964
10. Gallo RC, Perry S, Breitman TR: The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. J Biol Chem 242:5059-5058, 1967
11. Krenitsky TA: Pentosyl transfer mechanisms of the mammalian nucleoside phosphorylases. J Biol Chem 243:2871-2875, 1968
12. Kaut A, Yamada EW: Cytoplasmic uridine phosphorylase of rat liver. J Biol Chem 246:2021-2030, 1971
13. Voytek P: Purification of thymidine phosphorylase from Escherichia coli and its photoinactivation in the presence of thymine, thymidine, and some halogenated analogs. J Biol Chem 250:3660-3665, 1975
14. Blank JG, Hoffee PA: Purification and properties of thymidine phosphorylase from Salmonella typhimurium. Arch Biochem Biophys 168:259-265, 1975
15. Desgranges C, Razaka G, Rabaud H, et al: Catabolism of thymidine in human blood platelets: Purification and properties of thymidine phosphorylase. Biochim Biophys Acta 654:211-218, 1981
16. Furukawa T, Yoshimura A, Sumizawa T, et al: Angiogenic factor [letter]. Nature 356:668, 1992
17. Usuki K, Saras J, Waltenberger J, et al: Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 184:1311-1316, 1992
18. Moghaddam A, Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31:12141-12146, 1992
19. Sumizawa T, Furukawa T, Haraguchi M, et al: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biol Chem 114:9-14, 1993
20. Miyazono K, Heldin CH: High-yield purification of platelet-derived endothelial cell growth factor. Structural characterization and establishment of a specific antiserum. Biochemistry 28:1704-1710, 1989
21. Miyadera K, Sumizawa T, Haraguchi M, et al: Role of thymidine phosphorylase activity in angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55:1687-1690, 1995
22. Haraguchi M, Miyadera K, Uemura K, et al: Angiogenic activity of enzyme [letter]. Nature 368:198, 1994
23. Ishikawa F, Miyazono K, Hellman U, et al: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557-562, 1989
24. Patterson AV, Zhang H, Moghaddam A, et al: Increased sensitivity to the prodrug 5′-deoxy-5-flurouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72:669-675, 1995
25. Toi M, Inada K, Hoshina S, et al: Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1:961-964, 1996
26. Reynolds K, Farzaneh F, Collins WP, et al: Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86:1234-1238, 1994
27. The Japanese Urological Association, The Japanese Pathological Society and Japanese Radiological Society: General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma (in Japanese) (ed 2). Tokyo, Japan, Kanehara, 1992
28. Union International Contre le Cancer: TNM Atlas (ed 3, rev 2). Berlin, Germany, Springer-Verlag, 1992
29. Takebayashi Y, Yamada K, Miyadera K, et al: The expression and activity of thymidine phosphorylase in human solid tumours. Eur J Cancer 32:1227-1232, 1996
30. Bradford MA: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
31. Zar JH: Biostatistical Analysis (ed 3). Upper Saddle River, NJ, Prentice Hall, 1996
32. Breslow NE, Day NE: Statistical Methods in Cancer Research. IARC Scientific Publication No. 82. Lyon, France, IARC, 1987
33. Preston DL, Lubin JH, Pierce DA: EPICURE: Risk Regression and Data Analysis Software. Seattle, WA, Hirosoft International, 1990
34. Folkman J, Klagsbrun M: Angiogenic factors. Science 235:442-447, 1987
35. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res 46:467-473, 1986
36. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3:65-71, 1992
37. Sargent ER, Gomella LG, Belldegrun A, et al: Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. J Urol 142:1364-1368, 1989
38. Fujimoto K, Ichimori Y, Kakizoe T, et al: Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 180:386-392, 1991
39. Uhlman DL, Nguyen P, Manivel JC, et al: Epidermal growth factor receptor and transforming growth factor a expression in papillary and nonpapillary renal cell carcinoma: Correlation with metastatic behavior and prognosis. Cancer Res 1:913-920, 1995
40. O'Brien T, Cranston D, Fuggle S, et al: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55:510-513, 1995
41. Moghaddam A, Zhang HT, Fan TP, et al: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92:998-1002, 1995
42. Weinder N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis correlation in breast carcinoma. N Engl J Med 324:1-8, 1992
43. Weinder N, Carroll PR, Flax J, et al: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993
44. Jaeger TM, Weidner N, Chew K, et al: Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 154:69-71, 1995
45. Robson CJ, Churchill BM, Anderson W: The results of radical nephrectomy for renal cell carcinoma. J Urol 101:397-301, 1969
46. Nurmi MJ: Prognostic factors in renal cell carcinoma. An evaluation of operative findings. Br J Urol 56:270-275, 1984
47. Guinan PD, Vogelzank NJ, Fremgen AM, et al: Renal cell carcinoma: Tumor size, stage and survival. J Urol 153:901-903, 1995
48. Strohmeyer T, Ackermann R: Classic and modern prognostic indicators in renal cell carcinoma. Urol Int 47:203-212, 1991
49. Fox SB, Moghaddam A, Westwood M. et al: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study. J Pathol 176:183-190, 1995
50. Desgranges C, Rakaza G, Rabaud M, et al: The human blood platelet: A cellular model to study the degradation of thymidine and its inhibition. Biochem Pharmacol 31:2755-2759, 1982